Skip to main content
. Author manuscript; available in PMC: 2012 Aug 18.
Published in final edited form as: Pharmacopsychiatry. 2008 Mar;41(2):48–53. doi: 10.1055/s-2007-993211

Figure 2.

Figure 2

Serum content of the endocannabinoid 2-arachidonlyglycerol (2-AG) exhibited a significant negative correlation (r = −.492) with the duration of the current depressive episode (in weeks).